BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 38115276)

  • 1. Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment.
    Wang J; Ma G; Zhang P; Ma C; Shao J; Wang L; Ma C
    Medicine (Baltimore); 2023 Dec; 102(50):e36177. PubMed ID: 38115276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of Zicui Decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking].
    Gao LD; Liu J; Huang YH; Wang BH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3339-3347. PubMed ID: 35851128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of
    Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
    Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the mechanism of hirudin in the treatment of diabetic kidney disease using network pharmacology combined with molecular docking verification.
    Xinxin P; Qing Z; Zining P; Yage Z; Xiujie S; Jiarui H
    J Tradit Chin Med; 2022 Aug; 42(4):586-594. PubMed ID: 35848975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
    Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
    J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
    Wu Z; Ji X; Shan C; Song J; Zhao J
    Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential application of
    Che MY; Yuan L; Min J; Xu DJ; Lu DD; Liu WJ; Wang KL; Wang YY; Nan Y
    World J Diabetes; 2024 Mar; 15(3):530-551. PubMed ID: 38591077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.
    Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W
    Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
    He L; Shen K; He L; Chen Y; Tang Z
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potential Molecular Mechanism of the Shugan Jieyu Capsule in the Treatment of Depression through Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.
    Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
    Curr Comput Aided Drug Des; 2024; 20(5):501-517. PubMed ID: 37340752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
    Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Targets and Mechanisms of
    Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
    Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of modified Liangge San in treatment of acute respiratory distress syndrome based on network pharmacology and experimental validation].
    Li Q; Wang MM; Nie SN; Sun HJ; Tang C; Sun ZR
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6753-6762. PubMed ID: 36604925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
    Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
    Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
    Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis.
    Liu W; Yuan L; Che M; Hou S; Meng F; Xu D; Nan Y
    Medicine (Baltimore); 2023 Nov; 102(47):e36196. PubMed ID: 38013385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Pharmacology and Molecular Docking Analysis to Explore the Mechanism of Huaiqihuang-Mediated Alleviation of Henoch-Schönlein Purpura Nephritis.
    Liu Q; Liu J; Du Y; Guo W; Mi J; Guo Y
    Biomed Res Int; 2022; 2022():2798217. PubMed ID: 36389115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation.
    Chen S; Li B; Chen L; Jiang H
    J Transl Med; 2023 Jun; 21(1):380. PubMed ID: 37308949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.